A systematic review and meta‐analysis of clinical predictors of lithium response in bipolar disorder
Year: 2019
Type: review
Study designs: Systematic Review, Meta-Analysis
Abstract: OBJECTIVE: To determine clinical predictors of lithium response in bipolar disorder. METHODS: Systematic review of studies examining clinical predictors of lithium response was conducted. Meta-analyses were performed when ≥2 studies examined the same potential predictor. RESULTS: A total of 71 studies, including over 12 000 patients, identified six predictors of good response: mania-depression-interval sequence [odds ratio (OR): 4.27; 95% CI: 2.61, 6.97; P < 0.001], absence of rapid cycling (OR for rapid cycling: 0.30; 95% CI: 0.17, 0.53; P < 0.001), absence of psychotic symptoms (OR for psychotic symptoms: 0.52; 95% CI: 0.34, 0.79; P = 0.002), family history of bipolar disorder (OR: 1.61; 95% CI: 1.03, 2.52; P = 0.036), shorter prelithium illness duration [standardised mean difference (SMD): -0.26; 95% CI: -0.41, -0.12; P < 0.001] and later age of onset (SMD: 0.17; 95% CI: 0.02, 0.36; P = 0.029). Additionally, higher body mass index was associated with poor response in two studies (SMD: -0.61; 95% CI: -0.90, -0.32; P < 0.001). There was weak evidence for number of episodes prior to lithium treatment (SMD: -0.42; 95% CI: -0.84, -0.01; P = 0.046), number of hospitalisations before lithium (SMD: -0.40; 95% CI: -0.81, 0.01; P = 0.055) and family history of lithium response (OR: 10.28; 95% CI: 0.66, 161.26; P = 0.097). CONCLUSIONS: The relative importance of these clinical characteristics should be interpreted with caution because of potential biases and confounding.
Source: Acta Psychiatrica Scandinavica
DOI: 10.1111/acps.13062
Authors: T. P. Hui, A. Kandola, L. Shen, G. Lewis, D. P. J. Osborn, J. R. Geddes, J. F. Hayes
Institutions: University College London, University of Oxford
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: bipolar disorder, lithium, treatment response, predictors of treatment response, rapid cycling, psychotic symptoms, family history (medicine), disease duration, age of onset, body mass index, hospitalization, number of episodes, mood stabilizers, pharmacogenetics, genetic polymorphism, CYP2C9, CYP2C19, CYP3A4
Open Access status: hybrid
Estimated APC paid: $3,600
OpenAlex ID: W2952319084
